FINWIRES · TerminalLIVE
FINWIRES

Kaken Pharmaceutical Cuts Fiscal 2026 Profit Forecast on Milestone Payment Deferral

By

Kaken Pharmaceutical (TYO:4521) has lowered its consolidated earnings forecast for the fiscal year ending March 31 to 2.1 billion yen from 2.3 billion yen previously.

The pharmaceutical group now expects fiscal 2026 basic earnings per share to be 55.39 yen compared with 60.74 yen initially, and net sales to be lower at 76.9 billion yen versus 86.3 billion yen, according to a Tokyo bourse filing on Wednesday.

The downward revision was primarily driven by the deferral of a $70 million milestone payment from Johnson & Johnson, which was initially expected in fiscal 2026 but will now be recognized in the following year.

Further, the company factored in a reduction in research and development expenses aimed at improving investment efficiency, as well as the partial disposal of cross-shareholdings in line with its reduction policy announced in May 2024.

Kaken Pharmaceutical said these revisions reflect differences from the previous forecast announced on Sept. 26, 2025, and cautioned that actual results may vary due to forward-looking uncertainties.

Related Articles

Asia

China Minsheng Banking Issues 30 Billion Yuan Tier 2 Capital Bonds

China Minsheng Banking (SHA:600016, HKG:1988) issued Tier 2 capital bonds amounting to 30 billion yuan, according to a Shanghai bourse filing on Wednesday.The 10-year fixed-rate bonds have a coupon rate of 2.13%, with a conditional issuer call option at the end of the fifth year.Proceeds from the issuance will be used to supplement the lender's Tier 2 capital.The bank's Hong Kong shares slipped 1% during the morning trade.

HKG:1988SHA:600016
Asia

Kaishan 2025 Profit Up 14%, Revenue Rises 12%

Kaishan Group (SHE:300257) posted 2025 attributable net profit of 364.2 million yuan, up 14% from 320.4 million yuan the previous year.Earnings per share rose to 0.37 yuan from 0.32 yuan, according to a Wednesday filing with the Shenzhen bourse.The compressor maker's operating revenue rose 12% year over year to 4.72 billion yuan from 4.23 billion yuan.Shares of the company were down 1% in recent trade.

SHE:300257
Asia

Shanjin International Gold's Attributable Profit Jumps 101% in Q1

Shanjin International Gold's (SHE:000975) attributable profit rose 101% to 1.39 billion yuan in the first quarter from 693.8 million yuan in the year-ago period, according to a Wednesday filing with the Shenzhen bourse.Earnings per share at the mining company increased 101% to 0.5023 yuan from 0.2499 yuan in the prior-year period.Operating income grew 37% year over year to 5.94 billion yuan from 4.32 billion yuan.Shares increased 1% during the midday break on Wednesday.

SHE:000975